Filter Results :

Your search for Lymphoma returned 125 reports

Sort by


Hodgkin Lymphoma - Pipeline Review, H1 2015

22 Jan 2015  |  Published by:  Global Markets Direct
Summary‘Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment ...

$ 2,000.00

Read More

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Acute Lymphoblastic Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Lymphoblastic Lymphoma, complete with comparative analysis at var...

$ 2,000.00

Read More

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014

15 Dec 2014  |  Published by:  Global Markets Direct
Summary‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014’, provides an overview of the Anaplastic Large Cell Lymphoma (ALCL)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL), complete with c...

$ 2,000.00

Read More

Lymphoma Treatment Drugs Markets in China

01 Dec 2014  |  Published by:  Asia Market Info and Dev Co.
China's demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import &...

$ 4,000.00

Read More

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

21 Nov 2014  |  Published by:  GlobalData
SummaryThe Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare organization. The organization provides funding to blood cancer research, and offers education and patient services. It provides services, such as fund raising, patient services, health education, policy advocacy and medical research...

$ 300.00

Read More

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

21 Nov 2014  |  Published by:  GlobalData
SummaryThe Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare organization. The organization provides funding to blood cancer research, and offers education and patient services. It provides services, such as fund raising, patient services, health education, policy advocacy and medical research...

$ 250.00

Read More

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

10 Nov 2014  |  Published by:  KuicK Research
The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing rapid growth in Non Hodgkin Lymphoma segment. Past few decades have witnessed an increased...

$ 2,400.00

Read More

Lymphoma Partnering 2009-2014

01 Nov 2014  |  Published by:  CurrentPartnering
The Lymphoma Partnering 2009-2014 provides understanding and access to the lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of lymphoma partnering deals. The majority of deals are discovery or development stage...

$ 995.00

Read More

Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014

31 Oct 2014  |  Published by:  Global Markets Direct
Summary‘Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Cutaneous T-Cell Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cutaneous T-Cell Lymphoma, complete with comparative analysis at various stage...

$ 2,000.00

Read More

Indolent Lymphoma - Pipeline Review, H2 2014

31 Oct 2014  |  Published by:  Global Markets Direct
Summary‘Indolent Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Indolent Lymphoma, complete with comparative analysis at various stages, therapeutics assessme...

$ 2,000.00

Read More

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

31 Oct 2014  |  Published by:  GBI Research
Summary “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options”, which provides in-depth insight into the indication. It provides estimates of market size for 2013 along with forecast...

$ 4,995.00

Read More

T-Cell Lymphomas - Pipeline Review, H2 2014

31 Oct 2014  |  Published by:  Global Markets Direct
Summary‘T-Cell Lymphomas - Pipeline Review, H2 2014’, provides an overview of the T-Cell Lymphomas’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for T-Cell Lymphomas, complete with comparative analysis at various stages, therapeutics assessment ...

$ 2,000.00

Read More

Non-Hodgkin Lymphoma - Pipeline Review, H2 2014

30 Oct 2014  |  Published by:  Global Markets Direct
Summary‘Non-Hodgkin Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Non-Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics...

$ 2,000.00

Read More

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

15 Sep 2014  |  Published by:  GBI Research
Summary ‘Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting’, which provides in-depth insights into the indication. It gives an estimation of market size for 2013 along with forecasts until 2020 for...

$ 4,995.00

Read More

Burkitt Lymphoma - Pipeline Review, H2 2014

10 Sep 2014  |  Published by:  Global Markets Direct
Summary‘Burkitt Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Burkitt Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Burkitt Lymphoma, complete with comparative analysis at various stages, therapeutics assessment ...

$ 2,000.00

Read More
Total 125 records.